Aducanumab reduces Aβ plaques in Alzheimer's disease

被引：8
|
作者：
Vaillancourt, David E. [1 ,2 ]
机构：
[1] Univ Florida, Dept Neurol, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA
[2] Univ Florida, Dept Biomed Engn, Gainesville, FL 32611 USA
来源：
MOVEMENT DISORDERS | 2016年 / 31卷 / 11期
关键词：
PARKINSON DISEASE;
D O I：
10.1002/mds.26833
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1631 / 1631
页数：1
相关论文
共 50 条
  • [1] The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
    Jeff Sevigny
    Ping Chiao
    Thierry Bussière
    Paul H. Weinreb
    Leslie Williams
    Marcel Maier
    Robert Dunstan
    Stephen Salloway
    Tianle Chen
    Yan Ling
    John O’Gorman
    Fang Qian
    Mahin Arastu
    Mingwei Li
    Sowmya Chollate
    Melanie S. Brennan
    Omar Quintero-Monzon
    Robert H. Scannevin
    H. Moore Arnold
    Thomas Engber
    Kenneth Rhodes
    James Ferrero
    Yaming Hang
    Alvydas Mikulskis
    Jan Grimm
    Christoph Hock
    Roger M. Nitsch
    Alfred Sandrock
    Nature, 2016, 537 : 50 - 56
  • [2] The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
    Sevigny, Jeff
    Chiao, Ping
    Bussiere, Thierry
    Weinreb, Paul H.
    Williams, Leslie
    Maier, Marcel
    Dunstan, Robert
    Salloway, Stephen
    Chen, Tianle
    Ling, Yan
    O'Gorman, John
    Qian, Fang
    Arastu, Mahin
    Li, Mingwei
    Chollate, Sowmya
    Brennan, Melanie S.
    Quintero-Monzon, Omar
    Scannevin, Robert H.
    Arnold, H. Moore
    Engber, Thomas
    Rhodes, Kenneth
    Ferrero, James
    Hang, Yaming
    Mikulskis, Alvydas
    Grimm, Jan
    Hock, Christoph
    Nitsch, Roger M.
    Sandrock, Alfred
    NATURE, 2016, 537 (7618) : 50 - 56
  • [3] Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
    Jeff Sevigny
    Ping Chiao
    Thierry Bussière
    Paul H. Weinreb
    Leslie Williams
    Marcel Maier
    Robert Dunstan
    Stephen Salloway
    Tianle Chen
    Yan Ling
    John O’Gorman
    Fang Qian
    Mahin Arastu
    Mingwei Li
    Sowmya Chollate
    Melanie S. Brennan
    Omar Quintero-Monzon
    Robert H. Scannevin
    H. Moore Arnold
    Thomas Engber
    Kenneth Rhodes
    James Ferrero
    Yaming Hang
    Alvydas Mikulskis
    Jan Grimm
    Christoph Hock
    Roger M. Nitsch
    Alfred Sandrock
    Nature, 2017, 546 : 564 - 564
  • [4] The antibody aducanumab reduces Aβ plaques in Alzheimer's disease (vol 537, pg 50, 2016)
    Sevigny, Jeff
    Chiao, Ping
    Bussiere, Thierry
    Weinreb, Paul H.
    Williams, Leslie
    Maier, Marcel
    Dunstan, Robert
    Salloway, Stephen
    Chen, Tianle
    Ling, Yan
    O'Gorman, John
    Qian, Fang
    Arastu, Mahin
    Li, Mingwei
    Chollate, Sowmya
    Brennan, Melanie S.
    Quintero-Monzon, Omar
    Scannevin, Robert H.
    Arnold, H. Moore
    Engber, Thomas
    Rhodes, Kenneth
    Ferrero, James
    Hang, Yaming
    Mikulskis, Alvydas
    Grimm, Jan
    Hock, Christoph
    Nitsch, Roger M.
    Sandrock, Alfred
    NATURE, 2017, 546 (7659) : 564 - 564
  • [5] Aducanumab for Alzheimer's disease?
    Walsh, Sebastian
    Merrick, Richard
    Milne, Richard
    Brayne, Carol
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [6] ADUCANUMAB FOR ALZHEIMER'S DISEASE? Aducanumab, amyloid, and culture wars
    Iliffe, Steve
    Manthorpe, Jill
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [7] Aducanumab for the Treatment of Alzheimer's Disease
    Sarbacker, G. Blair
    US PHARMACIST, 2021, 46 (10) : 51 - 57
  • [8] Targeting Alzheimer's Disease With Aducanumab
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (06) : 580 - 580
  • [9] Aducanumab (Aduhelm) for Alzheimer's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1628): : 105 - 106
  • [10] A resurrection of aducanumab for Alzheimer's disease
    Schneider, Lon
    LANCET NEUROLOGY, 2020, 19 (02): : 111 - 112
12345